Literature DB >> 469015

Automated determination of red cell methaemoglobin reductase activity by a continuous-flow system for screening hereditary methaemoglobinaemia.

K Tanishima, N Fukuda, M Takeshita, Y Takizawa, T Kitamura, Y Yoneyama.   

Abstract

A flow diagram for the automated determination of ferricyanide reductase activity in red blood cells was prepared in the modules from AutoAnalyzer AA I (Technicon Instruments Inc). Ferricyanide reductase assay can be substituted for assay of cytochrome b5 reductase (EC 1.6.2.2), which plays a major role in reducing methaemoglobin in erythrocytes, and is defective specifically in the erythrocytes of patients with hereditary methaemoglobinaemia. The effective sampling rate of the analysis is 30/h, and less than 0.05 ml of whole blood is required. Interference of haemoglobin with absorption by potassium ferricyanide at 420 nm is effectively exculded by dialysis. This automated method was compared with the accepted diaphorase method, and it distinguished clearly the ferricyanide reductase activity of cord bloods from that of adult bloods. The activity of the blood from a patient with hereditary methaemoglobinaemia was only residual. It is suggested that the method is useful as a mass screening test for hereditary methaemoglobinaemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 469015      PMCID: PMC1145743          DOI: 10.1136/jcp.32.6.584

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Deficient activity of DPNH-dependent methemoglobin diaphorase in cord blood erythrocytes.

Authors:  J D ROSS
Journal:  Blood       Date:  1963-01       Impact factor: 22.113

2.  The enzymic defect of hereditary methemoglobinemia: diaphorase.

Authors:  E M SCOTT; I V GRIFFITH
Journal:  Biochim Biophys Acta       Date:  1959-08

3.  The relation of diaphorase of human erythrocytes to inheritance of methemoglobinemia.

Authors:  E M SCOTT
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

4.  Congenital methemoglobinemia in the newborn period.

Authors:  M S DINE
Journal:  AMA J Dis Child       Date:  1956-07

5.  The reduction of methaemoglobin in red blood cells and studies on the cause of idiopathic methaemoglobinaemia.

Authors:  Q H Gibson
Journal:  Biochem J       Date:  1948       Impact factor: 3.857

6.  Mental retardation in methemoglobinemia due to diaphorase deficiency.

Authors:  P J Fialkow; J A Browder; R S Sparkes; A G Motulsky
Journal:  N Engl J Med       Date:  1965-10-14       Impact factor: 91.245

7.  Catalysis of methaemoglobin reduction by erythrocyte cytochrome B5 and cytochrome B5 reductase.

Authors:  D E Hultquist; P G Passon
Journal:  Nat New Biol       Date:  1971-02-24

8.  Activity of NADH- and NADPH-dependent methemoglobin reductases in erythrocytes from fetal to adult age. A parallel assessment.

Authors:  M Vetrella; B Astedt; W Barthelmai; D Neuvians
Journal:  Klin Wochenschr       Date:  1971-09-01

9.  Purification of reduced pyridine nucleotide dehydrogenase from human erythrocytes and methemoglobin reduction by the enzyme.

Authors:  Y Sugita; S Nomura; Y Yoneyama
Journal:  J Biol Chem       Date:  1971-10-10       Impact factor: 5.157

10.  A colorimetric method for the specific determination of methemoglobin reductase activity in red blood cells.

Authors:  K Tanishima; M Takeshita; T Yubisui; Y Yoneyama
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1978-08
View more
  1 in total

1.  Genetic variation in CYB5R3 is associated with methemoglobin levels in preterm infants receiving nitric oxide therapy.

Authors:  Tyson D Fuller; Cassandra N Spracklen; Kelli K Ryckman; Lindsey A Knake; Tamara D Busch; Allison M Momany; Jeffrey C Murray; John M Dagle
Journal:  Pediatr Res       Date:  2014-12-18       Impact factor: 3.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.